The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. ACADIA Pharmaceuticals Inc.’s current trading price is -5.83% away from its 52-week high, while its distance from the 52-week low is 97.95%. The stock’s price range for this period has been between $12.24 and $25.73 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 0.83 million for the day, a number notably lower than the average daily volume of 1.66 million over the last three months.
The stock of ACADIA Pharmaceuticals Inc. (ACAD) is currently priced at $24.23. In the last session, the stock climbed significantly, topping out at $25.67 after opening at $25.42. The day’s lowest price was $25.03 before the stock closed at $25.65.
25-cent Stock Takes $11T Commodities Sector Digital
One brilliantly-run technology firm has successfully partnered with some of the largest players in the industry to bring a first-of-its-kind digital solution to the global commodities supply chain sector. Best of all, this upstart technology firm is currently trading undiscovered — below 25-cents per share — so very, very few investors know about it yet! For investors… it's an early-stage opportunity in a company that's bringing the US$11T global commodities sector straight into the 21st century.
All the details are in the FREE online report you can get here.
Sponsored
In terms of market performance, ACADIA Pharmaceuticals Inc. had a fairly even. The highest value for the stock in the past year was $25.73 on 05/25/23, and the lowest value was recorded at $12.24 on 06/21/22.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
ACADIA Pharmaceuticals Inc. (ACAD) has experienced a quarterly rise of 28.06% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 3.98B and boasts a workforce of 540 employees.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 19.77, with a change in price of +8.34. Similarly, ACADIA Pharmaceuticals Inc. recorded 1,495,719 in trading volume during the last 100 days, posting a change of +52.37%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for ACAD stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.
ACAD Stock Stochastic Average
As of today, ACADIA Pharmaceuticals Inc.’s raw stochastic average for the last 50 days stands at 78.59%. This is a rise compared to the raw stochastic average of the previous 20 days, which was noted at 68.33%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 87.88% and 94.83%, respectively.
ACAD Stock Price Performance Analysis
The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. The metric has seen a significant gain of 52.19% since the start of this calendar year. Looking back over the last six months, we can see a weaker performance of 61.10%. Over the past 30 days, the price of ACAD has fallen by 19.29%. And in the last five days, it has surged by 4.43%.
